US2023116233A1PendingUtilityA1

Compounds And Compositions As Protein Kinase Inhibitors

82
Assignee: ARRAY BIOPHARMA INCPriority: Aug 28, 2009Filed: Apr 20, 2022Published: Apr 13, 2023
Est. expiryAug 28, 2029(~3.1 yrs left)· nominal 20-yr term from priority
Inventors:Shenlin HuangXianming JinZuosheng LiuDaniel PoonJohn TellewYongqin WanXing WangYongping Xie
C07D 401/14C07D 403/04C07D 405/14A61K 31/506A61P 35/00A61P 25/24A61P 43/00A61K 31/4184A61P 1/08A61K 9/0053A61K 45/06
82
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Claims

exact text as granted — not AI-modified
1 . A compound which is 
       
         
           
           
               
               
           
         
         2-Chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl) pyrimidine.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.